{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:46:49Z","timestamp":1771663609449,"version":"3.50.1"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:p>Cannabinoids are part of the most popular group of illicit substances in the Western world. The word \u201ccannabinoid\u201d refers to any chemical substance, regardless of structure or origin, that binds to the body\u2019s cannabinoid receptors and that has effects similar to those produced by the Cannabis plant. Regarding their origin, cannabinoids can be classified into endocannabinoids, phytocannabinoids and synthetic cannabinoids. The behavioral and physiological effects of cannabinoids have received particular attention over the last few decades, including sensations of euphoria, relaxation and loss of concentration, with their repeated use being associated with short and long-term side effects, including respiratory and cardiovascular disorders, cognitive changes, psychoses, schizophrenia and mood disorders. On the other hand, recent investigations have proposed a promising therapeutic potential of cannabinoid-based drugs for a wide range of medical situations, including neurological and psychiatric disorders, among other indications. The growing popularity in the use of cannabinoid-based compounds, both for recreational and therapeutic purposes, has been accompanied by an equally continuous and growing evolution of knowledge regarding their potential harmful and beneficial effects. However, there are several open questions and challenges to be answered, which require more and better investigations. This article\u2019s main objectives are: i) to understand the importance of the action of cannabinoids in humans; ii) identify the different types of cannabinoids that exist and understand the differences in their action; iii) distinguish the legislative framework for cannabinoid consumption; iv) identify the possible adverse effects of cannabinoid consumption, as well as their potential benefits; v) know the existing medical-scientific evidence in terms of therapeutic potential, particularly in relation to aspects of safety and efficacy; vi) encourage critical thinking about the recreational consumption and therapeutic use of cannabinoids, based both on currently available evidence and gaps in knowledge.<\/jats:p>","DOI":"10.3389\/ftox.2024.1495547","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:40Z","timestamp":1738046620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use \u2013 a review"],"prefix":"10.3389","volume":"6","author":[{"given":"Helena M.","family":"Teixeira","sequence":"first","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"Abrams","year":"2015","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2147\/NDT.S107622","article-title":"Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients","volume":"12","author":"Altintas","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00216-021-03199-6","article-title":"Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures","volume":"413","author":"Alves","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10408444.2020.1762539","article-title":"The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review","volume":"50","author":"Alves","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/FPLS.2016.00019","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"B6","first-page":"126","article-title":"Cannabis sativa: therapeutic Chemistry and classification","volume":"5","author":"Bajpai","year":"2016","journal-title":"Res. Rev. J. Pharm. Analysis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J. Pain Symptom Manag."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0885-3924(97)00038-9","article-title":"Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia","volume":"14","author":"Beal","year":"1997","journal-title":"J. Pain Symptom Manag."},{"key":"B9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4137\/PMC.S32171","article-title":"The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation","volume":"8","author":"Bow","year":"2016","journal-title":"Perspect. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03602532.2013.839700","article-title":"The K2\/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products","volume":"46","author":"Brents","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1530-0277.1996.tb01075.x","article-title":"Prenatal exposure to alcohol and marijuana: effects on motor development of preschool children","volume":"20","author":"Chandler","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/FPUBH.2018.00162","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse effects-A review from public health prospective","volume":"6","author":"Cohen","year":"2018","journal-title":"Front. Public Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/CPT.1381","article-title":"Positive and negative effects of cannabis and cannabinoids on health","volume":"105","author":"Cohen","year":"2019","journal-title":"Clin. Pharmacol. and Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1468-1331.2006.01639.x","article-title":"Randomized controlled trial of cannabis\u2010based medicine in spasticity caused by multiple sclerosis","volume":"14","author":"Collin","year":"2007","journal-title":"Eur. J. Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1179\/016164109X12590518685660","article-title":"A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis","volume":"32","author":"Collin","year":"2010","journal-title":"Neurological Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0892-0362(91)90079-C","article-title":"Prenatal marijuana use and neonatal outcome","volume":"13","author":"Day","year":"1991","journal-title":"Neurotoxicology Teratol."},{"key":"B21","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"B22","volume-title":"Cannabis legislation in Europe","year":""},{"key":"B23","volume-title":"Medical use of cannabis and cannabinoids: questions and answers for policymaking","year":""},{"key":"B88","volume-title":"European Drug Report 2021: Trends and Developments","year":"2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5350\/DAJPN20132601001","article-title":"Synthetic cannabinoids: crisis of the decade","volume":"26","author":"Evren","year":"2013","journal-title":"Dusunen Adam J. Psychiatry Neurological Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuint.2011.11.004","article-title":"[\u00b9\u00b2\u2075I]SD-7015 reveals fine modalities of CB\u2081 cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease","volume":"60","author":"Farkas","year":"2012","journal-title":"Neurochem. Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ptr.3375","article-title":"Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation","volume":"25","author":"Farrimond","year":"2011","journal-title":"Phytotherapy Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: the new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/J.JFDA.2017.04.001","article-title":"New psychoactive substances of natural origin: a brief review","volume":"25","author":"Feng","year":"2017","journal-title":"J. Food Drug Analysis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's chorea, alzheimer's disease, and others","volume":"231","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Alzheimer\u2019s Dis. Others"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0195-6663(88)80017-5","article-title":"Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory","volume":"11","author":"Foltin","year":"1988","journal-title":"Appetite"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0892-0362(00)00119-7","article-title":"A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function","volume":"23","author":"Fried","year":"2001","journal-title":"Neurotoxicology Teratol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0892-0362(99)00009-4","article-title":"Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana","volume":"21","author":"Fried","year":"1999","journal-title":"Neurotoxicology Teratol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2014.12.003","article-title":"Identification of CB\u2082 receptors in human nigral neurons that degenerate in Parkinson's disease","volume":"587","author":"Garc\u00eda","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/01.wnl.0000304046.23960.25","article-title":"Multiple sclerosis and cannabis: a cognitive and psychiatric study","volume":"71","author":"Ghaffar","year":"2008","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1034\/j.1600-0773.2003.930202.x","article-title":"The CB 1 cannabinoid receptor agonist, HU\u2010210, reduces levodopa\u2010induced rotations in 6\u2010hydroxydopamine\u2010lesioned rats","volume":"93","author":"Gilgun\u2010Sherki","year":"2003","journal-title":"Pharmacol. and Toxicol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1124\/mol.56.6.1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB 1 and CB 2 receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"CD009270","DOI":"10.1002\/14651858.CD009270.pub3","article-title":"Cannabinoids for epilepsy","volume":"2014","author":"Gloss","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/10408444.2019.1679087","article-title":"Synthetic cathinones: an evolving class of new psychoactive substances","volume":"49","author":"Gon\u00e7alves","year":"2019","journal-title":"Crit. Rev. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/07352689.2016.1265360","article-title":"Medicinal uses of marijuana and cannabinoids","volume":"35","author":"Grotenhermen","year":"2016","journal-title":"Crit. Rev. Plant Sci."},{"key":"B40","first-page":"1","article-title":"Health aspects of cannabis","volume":"38","author":"Hollister","year":"1986","journal-title":"Pharmacol. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1212\/WNL.0B013E318212AB0C","article-title":"Effects of cannabis on cognitive function in patients with multiple sclerosis","volume":"76","author":"Honarmand","year":"2011","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2398212818783908","DOI":"10.1177\/2398212818783908","article-title":"Cannabinoid ligands, receptors and enzymes: pharmacological tools and therapeutic potential","volume":"2","author":"Hourani","year":"2018","journal-title":"Brain Neurosci. Adv."},{"key":"B43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0091-3057(91)90364-8","article-title":"The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells","volume":"40","author":"Howlett","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/WNP.0000000000000641","article-title":"Cannabis for pediatric epilepsy","volume":"37","author":"Huntsman","year":"2020","journal-title":"J. Clin. Neurophysiology"},{"key":"B45","unstructured":"Delibera\u00e7\u00e3o n.o 11\/CD\/2019\n          \n          \n          2019"},{"key":"B46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.nurpra.2017.05.014","article-title":"Role of the endocannabinoid system and medical cannabis","volume":"13","author":"Jarvis","year":"2017","journal-title":"J. Nurse Pract."},{"key":"B47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a north central cancer treatment group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.2042-7158.1984.tb04901.x","article-title":"Passive inhalation of cannabis smoke","volume":"36","author":"Law","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"B51","first-page":"1612","article-title":"Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids","volume":"268","author":"Lynn","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B53","first-page":"17","article-title":"Cannabis and bioactive cannabinoids","volume-title":"Studies in natural products Chemistry","author":"Messina","year":"2015"},{"key":"B54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10681-004-4758-7","article-title":"The sexual differentiation of Cannabis sativa L.: a morphological and molecular study","volume":"140","author":"Moliterni","year":"2004","journal-title":"Euphytica"},{"key":"B55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.talanta.2017.02.019","article-title":"Application of a rapid \u03bc-SPE clean-up for multiclass quantitative analysis of sixteen new psychoactive substances in whole blood by LC\u2013MS\/MS","volume":"167","author":"Montesano","year":"2017","journal-title":"Talanta"},{"key":"B56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/JCSM.12273","article-title":"Systematic review and meta-analysis of cannabinoids in palliative medicine","volume":"9","author":"M\u00fccke","year":"2018","journal-title":"J. Cachexia, Sarcopenia Muscle"},{"key":"B57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpain.2007.10.018","article-title":"Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy","volume":"9","author":"Narang","year":"2008","journal-title":"J. Pain"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1468-1331.2010.03328.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex \u00ae), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis","volume":"18","author":"Novotna","year":"2011","journal-title":"Eur. J. Neurology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.7150\/IJMS.27087","article-title":"Cannabinoids: from pot to lab","volume":"15","author":"Papaseit","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/WNL.0000000000000446","article-title":"Effects of cannabis on cognition in patients with MS: a psychometric and MRI study","volume":"82","author":"Pavisian","year":"2014","journal-title":"Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"569958","DOI":"10.3389\/fpls.2020.569958","article-title":"Genetic architecture of flowering time and sex determination in hemp (cannabis sativa L.): a genome-wide association study","volume":"11","author":"Petit","year":"2020","journal-title":"Front. Plant Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1021\/jm970136g","article-title":"Importance of the C-1 substituent in classical cannabinoids to CB 2 receptor selectivity: synthesis and characterization of a series of O,2-Propano-\u0394 8 -tetrahydrocannabinol analogs","volume":"40","author":"Reggio","year":"1997","journal-title":"J. Med. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington\u2019s disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13311-015-0380-8","article-title":"Safety and toxicology of cannabinoids","volume":"12","author":"Sachs","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"101301","DOI":"10.1016\/j.isci.2020.101301","article-title":"Cannabinoids and cannabinoid receptors: the story so far","volume":"23","author":"Shahbazi","year":"2020","journal-title":"IScience"},{"key":"B70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.54108\/10032","article-title":"The therapeutic use of cannabis and cannabinoids","volume":"47","author":"Silva","year":"2022","journal-title":"Rev. Espa\u00f1ola Drog."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"","journal-title":"Pain"},{"key":"B72","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/JNNP-2017-317168","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"89","author":"Stockings","year":"","journal-title":"J. Neurology, Neurosurg. and Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0091-3057(91)90377-E","article-title":"Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC","volume":"40","author":"Tashkin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B74","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/J.FORSCIINT.2004.09.002","article-title":"Cannabis and driving: the use of LC\u2013MS to detect \u03949-tetrahydrocannabinol (\u03949-THC) in oral fluid samples","volume":"146","author":"Teixeira","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/J.FORSCIINT.2004.11.026","article-title":"Analysis of Delta9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry","volume":"150","author":"Teixeira","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"B76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.forsciint.2007.03.026","article-title":"Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization","volume":"170","author":"Teixeira","year":"2007","journal-title":"Forensic Sci. Int."},{"key":"B77","first-page":"187","article-title":"Canabin\u00f3ides","volume-title":"Toxicologia forense","author":"Teixeira","year":"2015"},{"key":"B78","first-page":"731","article-title":"Drogas de abuso","volume-title":"Tratado de Medicina Legal","author":"Teixeira","year":"2022"},{"key":"B79","article-title":"Cannabinoids: forensic toxicology and therapeutics","volume-title":"Forensic medicine - from old problems to new challenges","author":"Teixeira","year":"2011"},{"key":"B80","volume-title":"The analytical Chemistry of cannabis: quality assessment, assurance, and regulation of medicinal marijuana and cannabinoid preparations","author":"Thomas","year":"2016"},{"key":"B81","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/aid.1997.13.305","article-title":"The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 004 Study Group. Division of AIDS Treatment Research Initiative","volume":"13","author":"Timpone","year":"1997","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"B82","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/08897077.2016.1219438","article-title":"Acute effects of synthetic cannabinoids: update 2015","volume":"38","author":"Tournebize","year":"2017","journal-title":"Subst. Abuse"},{"key":"B83","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/pme.12569","article-title":"Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial","volume":"16","author":"Turcotte","year":"2015","journal-title":"Pain Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMRA1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1503\/CMAJ.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ"},{"key":"B87","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/IJMS19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2024.1495547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:43:48Z","timestamp":1738046628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2024.1495547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":85,"alternative-id":["10.3389\/ftox.2024.1495547"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2024.1495547","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"article-number":"1495547"}}